Atorvastatin Oxirane Impurity is a chemical compound identified as a process-related byproduct in the synthesis of atorvastatin, a statin medication. It is defined by an oxirane ring structure containing a fluorobenzoyl and diphenylcarboxamide group, and is primarily used as a reference standard in pharmaceutical quality control and research.
Sourcing Atorvastatin Oxirane Impurity?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
2-((5-Bromopyrimidin-2-yl)oxy)ethan-1-ol
research compound
5,6-Dihydroxyindan-1-one
chemical compound
N-[(E)-1-cyclohexa-2,4-dien-1-yl-3-phenylprop-2-enylidene]-4-[2,5-di(carbazol-9-yl)carbazol-9-yl]-3,5-diphenylbenzenecarboximidamide
not applicable
2-Ethoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-6-(trifluoromethyl)pyridine
research reagent
3-((4-fluorophenyl)carbonyl)-2-(2-methylpropanoyl)-N,3-diphenyloxirane-2-carboxamide
pharmaceutical intermediate
Sourcing Atorvastatin Oxirane Impurity?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
3-(4-fluorobenzoyl)-2-(2-methylpropyl)-N,3-diphenyloxirane-2-carboxamide
WTTRRISNQAPVTN-UHFFFAOYSA-N
CC(C)CC1(C(O1)(C2=CC=CC=C2)C(=O)C3=CC=C(C=C3)F)C(=O)NC4=CC=CC=C4